Ashenafi Sendekie | Pharmaceutical Policy and Regulation | Best Researcher Award

Published on by Top Pharmaceutical

Ashenafi Sendekie | Pharmaceutical Policy and Regulation | Best Researcher Award

Mr Ashenafi Sendekie, Curtin University, Australia

Mr. Ashenafi Kibret Sendekie is a dedicated researcher and academic pursuing a Ph.D. at Curtin University, focusing on ethical dilemmas in pharmacist-administered vaccinations for children and adolescents. 🎓 He holds a Master’s in Clinical Pharmacy and a Bachelor’s in Pharmacy from the University of Gondar. 📚 With numerous publications in SJR Q1 journals, his research spans AI in pharmacy, mental health, and public health. 🧠 As a lecturer and former Head of Hospital Pharmacy, he excels in teaching, leadership, and community service. 💊 His commitment to healthcare ethics and professional development makes him a standout in pharmacy research. 🌍

Publication Profile

google scholar

Education

Ashenafi Sendekie is a dedicated scholar currently pursuing a Ph.D. in Pharmacy at Curtin University, Australia 🇦🇺 (2024–present). His research focuses on exploring pharmacists’ experiences and ethical dilemmas in administering vaccines to children and adolescents using a mixed-methods approach 💉📊. He earned a Diploma in Teaching Methodology from the University of Gondar, Ethiopia 🇪🇹 (2020–2021), and an MSc in Clinical Pharmacy from the same institution (2018–2020) 🧪📚. Ashenafi began his academic journey with a Bachelor of Science in Pharmacy from the University of Gondar (2009–2014) 🎓. His commitment to pharmacy and education exemplifies his passion for improving healthcare outcomes 🌟.

Professional Membership

Ashenafi Sendekie is a proactive professional serving as the Chairperson of the Ethiopian Pharmaceutical Association (EPA), Gondar Chapter Executive Committee, since January 2023 🌍💊. He is also an active member of the Ethiopian Public Health Association (EPHA) 🏥. Ashenafi is known for his exceptional skills, including being a fast learner 🧠, maintaining a positive attitude 🌟, and excelling in time management ⏳ and attention to detail 🔍. His strong communication skills 🗣️, reliability ⏰, computer proficiency 💻, and teamwork 🤝 make him a valuable asset in any setting. Ashenafi’s organizational expertise ensures efficiency and success in his endeavors 📋✔️.

Journals Reviewer

Ashenafi Sendekie has actively contributed to renowned international journals as an author and researcher 🖋️🌍. His work is featured in prestigious publications, including PLOS Global Public Health 🌐, BMJ Open 📖, and Nature (Scientific Reports) 🔬. He has also contributed to journals like Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 🩺, Patient Preference and Adherence 💊, and BMC Health Services Research 🏥. Other notable journals include F1000Research 🔎, BMC Endocrine 💡, Integrated Pharmacy Research and Practice ⚕️, and BMJ Open Respiratory Research 🌬️. Ashenafi’s scholarly efforts reflect his commitment to advancing global health and pharmacy research 📚✨.

Collaboration

Ashenafi Sendekie is a committed contributor to the Global Burden of Disease (GBD) Collaboration 🌍📊, based at the Institute for Health Metrics and Evaluation (Hans Rosling Center for Population Health) in Seattle, WA, USA 🇺🇸. Since December 17, 2024, he has served as a GBD Senior Collaborator 🌟, following his role as a GBD Collaborator from April 2023 to December 16, 2024 📈. Ashenafi’s work in this global initiative highlights his dedication to advancing population health and contributing to impactful research aimed at improving health outcomes worldwide 🌐✨.

Conferences

Ashenafi Sendekie has actively participated in key academic events and presented his work on an international stage 🌍🎤. He presented a paper at the 5th Annual Conference of the Australian-based Ethiopian Researchers Network (ABReN) on August 31, 2024 📅. He also took part in the International Pharmaceutical Federation (FIP) PPR SIG 2024 Virtual Meeting on July 4, 2024 💻. Additionally, Ashenafi delivered an oral presentation at the 43rd Annual Conference of the Ethiopian Pharmaceutical Association held in Addis Ababa, Ethiopia, from July 28-29, 2023 🇪🇹💊. His active involvement highlights his commitment to advancing pharmaceutical research and knowledge sharing 📚.

Honors and Awards

Ashenafi Sendekie has received numerous prestigious awards throughout his academic journey 🎓🏆. In November 2023, he was awarded the 2024 HDR Curtin Scholarship at Curtin University, Australia 🇦🇺, providing a tuition fee offset and a stipend of $33,220 per annum for three years, with a possible six-month extension 💵. Earlier, in August 2023, he was offered admission for a Doctor of Philosophy in Pharmacy at Curtin University 🧪. In November 2022, Ashenafi received the Community Service Project Award from the University of Gondar, Ethiopia 🇪🇹, for his project improving pharmacists’ roles in patient counseling 💬. He also received research and scholarship grants for his master’s studies in clinical pharmacy 💡.

Current Residence

Ashenafi Sendekie currently resides at UniLodge at Curtin University – Guild House 🏠, located at 21.2, 63 Jackson Road, Karawara, WA, 6152, Australia 🇦🇺. This accommodation provides him with a comfortable and convenient living space close to Curtin University, supporting his academic pursuits 🧑‍🎓. As a Ph.D. student in Pharmacy, Ashenafi is able to focus on his studies while enjoying a supportive community environment at UniLodge 🌟. The location offers access to university facilities and enhances his experience as an international student in Australia 🌍.

Research Focus

Dr. Ashenafi Sendekie is a researcher with a strong focus on pharmacology, medication adherence, and chronic disease management. His work investigates the impact of medications, particularly for conditions like type 2 diabetes, asthma, and psychiatric disorders, while emphasizing patient education, medication safety, and adverse drug reactions. Dr. Sendekie also explores healthcare delivery in Ethiopia, including the roles of community pharmacists and the quality of life in patients managing chronic diseases. His research aims to improve medication adherence, reduce drug interactions, and enhance patient outcomes in low-resource settings. 🩺💊📊

Publication Top Notes

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia

Assessment of community pharmacy professionals’ knowledge and counseling skills achievement towards headache management: a cross-sectional and simulated-client based mixed study

Evaluation of antibiotics residues in milk and meat using different analytical methods

Impact of personal, cultural and religious beliefs on medication adherence among patients with chronic diseases at university hospital in Northwest Ethiopia

Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia

Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational …

SAEID ZEINALI HERIS | Antibiotic Resistance | Best Researcher Award

Published on by Top Pharmaceutical

SAEID ZEINALI HERIS | Antibiotic Resistance | Best Researcher Award

Prof SAEID ZEINALI HERIS, Xi’an University od Science nd Technology, China

Prof. SAEID ZEINALI HERIS is an accomplished chemical engineer with a Ph.D. from Isfahan University of Technology. His expertise includes nanofluids, heat transfer, and thermophysical properties. He has been recognized as a top 1% active scientist in engineering from 2016-2023. Prof. Zeinali Heris serves as an Associate Editor for several scientific journals and has led numerous industrial and research projects related to nanomaterials, gas refineries, and energy efficiency. He currently teaches at Xi’an University of Science and Technology and has extensive experience in academic and industrial research. 🌍📚⚙️🔬

Publication Profile

google scholar

Education

Prof. SAEID ZEINALI HERIS holds a Ph.D. in Chemical Engineering from Isfahan University of Technology (2000-2006), where his thesis focused on the experimental investigation of nanofluid laminar flow convective heat transfer through circular tubes under constant wall temperature. He also earned his M.Sc. in Chemical Engineering from the same university (1997-1999), with a thesis on the mathematical calculation and construction of a falling cylinder rheometer. Prof. Zeinali Heris completed his B.S. in Chemical Engineering at the University of Tehran (1992-1996). His work combines theoretical and experimental methods in chemical engineering. 🎓🔬🔥

Experience

Prof. SAEID ZEINALI HERIS is a distinguished academic and researcher currently serving at Xi’an University of Science and Technology (2022-present). He has an extensive career, including roles as the Head of the Faculty of Chemical and Petroleum Engineering at the University of Tabriz (2018-2022), and Vice-Chancellor of the same faculty (2017-2018). A professor since 2015, he has also held key management positions such as Manager of IAChE’s North & East Branch. Prof. Zeinali’s work spans various research projects, including advancements in nano-coating fire retardants and nanofluid pool boiling. His contributions in chemical engineering are well-recognized. 🏫🔬🔥📚

Honors

Prof. SAEID ZEINALI HERI is recognized as one of the top 1% active scientists in Engineering for multiple consecutive years, from 2016 to 2023. His dedication and groundbreaking contributions to the field have earned him this prestigious distinction year after year. His consistent excellence and innovative research have significantly impacted the engineering community, establishing him as a leading figure in his domain. With such an outstanding achievement, Prof. Zeinali Heri continues to inspire and push the boundaries of engineering science. 🏅🔬🌍📚🎓

Industrial Project

Prof. SAEID ZEINALI HERIS has contributed extensively to industrial advancements, especially in natural gas and petrochemical sectors. From 2015 to 2022, his work with Iran Natural Gas Company and other organizations focused on innovative applications of nanotechnology. Projects included the development of fire-retardant nano-coatings for gas refineries, enhancing the efficiency of heaters using functionalized carbon nanotubes, and improving the performance of gas turbine meters. His research also involved investigating the impact of nanoparticles on hydrate formation, wastewater treatment, and the optimization of fuel consumption in gas appliances. His work in nanotechnology continues to shape the industry. 🌱💡🔬⚙️

Research Focus

Prof. SAEID ZEINALI HERIS focuses on experimental and numerical investigations in heat transfer, specifically through the use of nanofluids. His research involves enhancing heat transfer in systems such as photovoltaic thermal units (PV/T), solar stills, and heat exchangers by incorporating nanofluids like Al2O3, TiO2, and silica. He also explores the effects of nanofluids on the thermal performance of engines and radiators. His work spans various applications in energy systems, including solar energy, thermosyphons, and nanolubricants. Additionally, Prof. Heris contributes to studies on exergy analysis, sustainable chemical processes, and thermal efficiencies. 🌡️🔬💧⚡

Publication Top Notes

Experimental investigation of oxide nanofluids laminar flow convective heat transfer

Experimental investigation of convective heat transferof Al2O3/water nanofluid in circular tube

Experimental investigation of the effects of silica/water nanofluid on PV/T (photovoltaic thermal units)

Nanofluids effects on the evaporation rate in a solar still equipped with a heat exchanger

Heat transfer enhancement using Al2O3/water nanofluidin a two-phase closed thermosyphon

Numerical investigation of nanofluid laminar convective heat transfer through a circular tube

Experimental comparison between ZnO and MoS2 nanoparticles as additives on performance of diesel oil-based nano lubricant

 

SooHo Yeo | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

SooHo Yeo | Nanomedicine | Best Researcher Award

Dr SooHo Yeo, College of Pharmacy & Yonsei Institute of Pharmaceutical Sciences, Yonsei University, South Korea

Dr. SooHo Yeo is a research professor at Yonsei University, specializing in pharmaceutics, cosmeceutics, and photodynamic therapy. He holds a Ph.D. in pharmacy from Chung-Ang University, where he focused on artificial skin formulations for topical delivery of adenosine. Dr. Yeo’s research interests include nano/micro-particles, skin absorption, and pharmacokinetic/pharmacodynamic analysis, with applications in cancer treatment and cosmetic clinical tests. He has published numerous studies on nanoparticle-based cancer therapies and anti-adhesive agents. His work contributes significantly to skin irritation, absorption studies, and enhancing anticancer therapies. 🧴💡🔬📚🎓

Publication Profile

Scopus

Education

Dr. SooHo Yeo is a distinguished scholar in the field of pharmacy, having completed his M.S./Ph.D. at the College of Pharmacy, Chung-Ang University, Seoul, Korea, in 2021. His research focused on developing innovative solutions for drug delivery, with his dissertation titled “Artificial Skin Formulation for Topical Delivery of Adenosine.” 🌱💊 His work combines pharmaceutical science and cutting-edge technology to enhance therapeutic efficacy through topical applications. Dr. Yeo’s contributions aim to revolutionize treatments by improving the delivery mechanisms of crucial compounds like adenosine, benefiting patients worldwide. 🧴🌏

Experience

Dr. SooHo Yeo is a dedicated researcher with extensive experience in the field of pharmacy and nanoscience. Since 2023, he has been a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea. Prior to this, he served as a Research Professor at the Department of Nanoscience and Engineering, INJE University, Gimhae, Korea, from 2021 to 2023. With a strong focus on advancing research in these fields, Dr. Yeo has made significant contributions to the scientific community. 🔬📚💉🌱

Research Fields

Dr. SooHo Yeo specializes in pharmaceutics and cosmeceutics, focusing on nano/micro-particles, solid dispersion, emulsions, liposomes, films, creams, and inhalers. His research integrates biology and toxicology, including in vitro skin irritation and absorption studies, using cells and reconstructed human epidermis tissues (following OECD guidelines), along with cellular uptake observed through confocal microscopy. Dr. Yeo also conducts pharmacokinetic and pharmacodynamic analysis for anti-cancer and anti-adhesive agents. His cosmetic clinical tests include skin wrinkle and moisture assessments. Additionally, he explores photodynamic therapy, advancing treatments for skin care and cancer therapies. 💉🧴🧬🔬💆‍♀️

Research Focus

Dr. SooHo Yeo’s research primarily focuses on nanotechnology for cancer treatment, particularly in the development of advanced drug delivery systems. His work involves the use of nanoparticles, such as PLGA and solid lipid nanoparticles, to enhance the efficacy of photodynamic therapy (PDT) and chemotherapy. Through innovative drug encapsulation methods, including for agents like Purpurin-18-N-hydroxylimide methyl ester, Dr. Yeo aims to improve therapeutic outcomes in cancer treatment. His studies also explore the use of smart nanoparticles for targeting specific organelles like mitochondria or lysosomes to optimize treatment precision and minimize side effects. 🧬💉🔬💊

Publication Top Notes

Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester

4-Hexylresorcinol Loaded Solid Lipid Nanoparticles for Enhancing Anticancer Activity

Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment

Polysaccharide-based emulsion gels for the prevention of postoperative adhesions and as a drug delivery system using 5-fluorouracil

Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy

Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy

Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy

Transition metal-dependent heavy-atom effect of metallochlorin photosensitizers for enhanced photodynamic therapy

pH-Responsive Nano-transferosomes of Purpurin-18 Sodium Salt and Doxorubicin for Enhanced Anticancer Efficiency by Photodynamic and Chemo Combination Therapy

Long-Wavelength Absorbing Benzimidazolo-Chlorin for Enhanced Photodynamic Therapy

 

 

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Dr Shoaeb Mohammad Syed, Dayanand College of Pharmacy Latur, India

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India. With extensive experience in pharmaceutics, formulation development, and novel drug delivery systems, he mentors M.Pharm and Ph.D. students and guides research projects. He has two granted patents and authored several books and research publications. Dr. Syed is actively involved in curriculum development, research mentorship, and academic leadership. His work spans areas like drug delivery, nano drug systems, and quality control. He has also contributed to multiple national and international conferences. 🏫💊📚🔬📜💡🎓

Publication Profile

Google Scholar

Education

Dr. Shoaeb Mohammad Syed holds a PhD in Pharmacy from Govt. College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad (2014-2019). He completed his postgraduate studies in Pharmaceutics at Y B Chavan College of Pharmacy, Dr. BAMU Aurangabad, securing 74.45% (2010-2012). He earned his undergraduate degree in Pharmacy from the same institution with 69.79% (2007-2010). Additionally, he obtained a D. Pharmacy from MSBTE Mumbai, achieving 80.60% (2005-2007). Dr. Syed’s academic journey showcases his dedication and expertise in the field of pharmacy. 🎓💊📚

Experience

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India, where he leads research, supports faculty programs, and mentors PhD students. He contributes to curriculum development, research projects, and patent filing. Previously, he was an Assistant Professor at Dr. Vedprakash Patil Pharmacy College, developing publications and managing research proposals. His role as a Research Fellow at Govt. College of Pharmacy focused on formulation development and GMP. Dr. Syed has extensive teaching experience across multiple institutions, creating courses, mentoring students, and publishing research. 📚💡📝🔬🎓

Academic Leadership and Mentoring

Dr. Shoaeb Mohammad has demonstrated exemplary leadership in academia through his guidance of Ph.D. students, fostering a supportive environment for academic growth. His active involvement in research proposal development and grant management underscores his dedication to driving innovative research. Dr. Mohammad’s commitment to academic development is further highlighted by his efforts in organizing conferences and workshops, which contribute to the exchange of knowledge and collaboration within the academic community. His work not only supports the academic growth of individuals but also strengthens the overall academic environment, making a lasting impact on the field. 🌍🎤📚

Professional Impact

Dr. Shoaeb Mohammad, known for his expertise in pharmaceutical sciences, has made significant contributions both in academia and the pharmaceutical industry. With a strong presence in scientific writing, he excels in drafting patents and reviewing manuscripts for various journals, ensuring the advancement of pharmaceutical research. His work spans national and international platforms, influencing the development of the field. Dr. Shoaeb’s commitment to innovation and quality in scientific publishing is evident in his dedication to enhancing the global pharmaceutical landscape. His diverse skills and impact continue to shape the future of pharmaceutical sciences. 🏭📑🌍

Research Focus

Dr. Shoaeb Mohammad Syed’s research focus revolves around the development and evaluation of advanced drug delivery systems. His work emphasizes osmotic drug delivery, gastroretentive systems, and transdermal delivery using novel carriers like ethosomes. He has contributed significantly to the analytical validation of pharmaceutical methods, such as UV spectrophotometry and RP-HPLC for drug estimation. His studies also include controlled-release formulations, such as osmotic tablets for sustained drug release, and the application of microsponges in topical drug delivery. Dr. Syed’s expertise in pharmaceutical formulations and analytical techniques aims to enhance drug bioavailability and therapeutic efficacy. 🧪💊📊

Achievements

Dr. Shoaeb Mohammad is a highly accomplished professional with a strong academic background. He qualified GPAT in 2010, was awarded the AICTE scholarship for his post-graduation, and excelled in the NIPERJEE 2010. He received the UGC-MANF fellowship for his PhD and emerged as the winner of Avishkar Research Convention 2019 at Dr. BAMU, Aurangabad, and was selected for the State Level Avishkar 2020 at the University of Mumbai. Dr. Mohammad developed the MDR Shifa Oil (Pain Relief Liniment), which was approved by the FDA Maharashtra, India. 🏆🎓💊👨‍🔬

Publication Top Notes

Osmotic Drug Delivery System: An Overview.

AN OVERVIEW OF GASTRORETENTIVE DRUG DELIVERY SYSTEM RESEARCH

Transdermal delivery of ethosomes as a novel vesicular carrier for paroxetine hydrochloride: In vitro evaluation and In vivo study

Validation of UV Spectrophotometric Method For Determination of Atenolol

Analytical Method Development and validation of RP-HPLC Method for Determination of Eletriptan HBr.

Controlled Porosity Osmotic Tablet of Atenolol: In-Vitro and In-Vivo Evaluation

Quality by Design: An Approach for Formulation Development

 

 

Smriti Bansal | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Smriti Bansal | Nanomedicine | Best Researcher Award

Ms Smriti Bansal, Netaji Subhas University of Technology, India

Ms. Smriti Bansal is a Ph.D. candidate in Chemistry, specializing in nanoparticle fabrication, water remediation, drug delivery, and antimicrobial studies. Her research focuses on creating transition metal-based nanoparticles for catalytic studies, contributing to both environmental sustainability and medicinal chemistry. She has authored high-impact publications in journals like ACS Applied Biomaterials and Ceramics International, and presented her work at international conferences. A research fellow at Netaji Subhas University of Technology, she is also a reviewer for top journals. Her leadership, interdisciplinary contributions, and recognition make her a deserving candidate for the Best Researcher Award.

Publication Profile

google scholar

Academic Qualification

Ms. Smriti Bansal is a dedicated academician with a strong background in chemistry. She completed her Ph.D. in Chemistry from Netaji Subhas University of Technology, Dwarka, New Delhi, in 2019 (thesis submitted). She earned her M.Sc. in Organic Chemistry from PDMU, Department of Chemistry, with an impressive 87.2% in 2018. Her B.Sc. in Analytical Chemistry from the University of Delhi (2015) further solidified her expertise, with a notable 78% score. Smriti’s academic journey began at Triveni Memorial Sr. Sec. School, where she excelled in both her H.S.C. (82.8%) and S.S.C. (83.6%) exams. 🎓🔬📚

Teaching Experience

Smriti Bansal is a dedicated academic professional with a strong background in chemistry. She currently serves as a Teaching Research Fellow at the Department of Chemistry, Netaji Subhas University of Technology, Dwarka, New Delhi, where she has been contributing to the field of Engineering Chemistry and Organic Chemistry since December 19, 2019. 📚🔬 Previously, she held the position of Assistant Professor at the Department of Applied Sciences, Delhi Technical Campus, Maharshi Dayanand University, where she taught Engineering Chemistry for one year. Her passion for research and teaching continues to inspire students and elevate the academic community. 👩‍🏫📖

Achievements

Ms. Smriti Bansal has made significant contributions to the field of nanotechnology and research. She successfully completed the “Nanotechnology: A Maker’s Course” online program, offered by Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill through Coursera 🎓. She also serves as a reviewer for prestigious journals such as the International Journal of Biological Macromolecules by Elsevier and the Indian Journal of Physics by Springer 📚. Her research on “Fabrication and Photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation” earned her the Commendable Research Award 🏆. Additionally, she is a life member of the Society of Young Biomedical Scientists (SYBS), India 🔬.

Conferences Attended

Ms. Smriti Bansal has actively participated in various prominent workshops and conferences to enhance her expertise. She attended the 7th Workshop on Computational Chemistry of Materials (CCM-2022) organized by the Centre for Advanced Computational Chemistry Studies, Delhi 🧑‍🔬. She also took part in the 5-day residential training program on Pre-Clinical Development of Medicinal and Aromatic Plant-Based Leads at CSIR-CIMAP, Lucknow 🌿. Ms. Bansal participated in the Organic Chemistry Series (OCS-2024) on catalysis for green synthesis 🌱, and the Fostering Sustainable Catalysis – 2024 event 🔬. Furthermore, she joined the National Conference on Environmental Sustainability in Wastewater Remediation (ESWR-2017) and on e-learning MOOCs & Quality in Higher Education 📚.

work Presented

Ms. Smriti Bansal has actively presented her research at numerous prestigious conferences. She delivered an oral talk on “Functionalized Chitosan-Coated Vanadium Pentoxide Nanoparticles” at the Fifth Science Conclave and NBRCOM 2024, organized by AIIMS and SCMM, JNU 🧑‍🔬. Additionally, she presented her work on “DECORATED VANADIUM PENTOXIDE NANODRUGS” at the International Symposium on Advanced Materials (CTAM-2024) 🎤. She also shared her research at AMSET-2023 in Malaysia on photocatalytic evaluation 🌏, and at ICONPAC-2022 on nano-photocatalysts 🌱. Ms. Bansal has contributed to multiple other conferences, including ICRACS-2022, and presented posters and papers on diabetes treatment and water remediation 🌊.

Research Focus

Smriti Bansal’s research focuses on the development of advanced nanomaterials for environmental and biomedical applications. She investigates the fabrication of functionalized nanomaterials, such as chitosan-decorated vanadium pentoxide nanoparticles, for water remediation, photocatalysis, and drug delivery systems. Her work also explores green synthesis approaches for vanadium nanoparticles, emphasizing sustainability and environmental protection. Bansal’s interdisciplinary studies extend into antibacterial, antioxidant, and cytotoxic activities, alongside in silico molecular docking for drug design. Her research has significant implications in environmental sustainability, nanotechnology, and healthcare. 🌍🔬💊

Publication Top Notes

Fabrication and photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation

A review on green approaches utilizing phytochemicals in the synthesis of vanadium nano particles and their applications

Direct synthesis of Poly (Ԑ-Caprolactone)-block-poly (glycidyl methacrylate) copolymer and its usage as a potential nano micelles carrier for hydrophobic drugs

In vitro Antibacterial Evaluation and in silico Docking of Schiff Base as a Potential Inhibitor of Nucleoside Diphosphate Kinases
Green Nanocomposites: Incorporating Biopolymers into Plastics for Enhanced Environmental Sustainability
Vanadium Pentoxide-Based Nanomaterials for the Treatment of Dye-Containing Wastewater to Avoid Negative Effects on the Environment and Human Health

Roxana Matran | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Roxana Matran | Pharmacology | Best Researcher Award

Assist Prof Dr Roxana Matran, UMF “Carol Davila”, Romania

Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic with a Ph.D. from Carol Davila University of Medicine and Pharmacy (2017) 🎓. An Assistant Professor at the same university since 2019, she excels in teaching and research on pediatric pulmonology and gastroenterology. Her clinical expertise at “Grigore Alexandrescu” Emergency Hospital for Children includes contributions to groundbreaking clinical trials on inflammatory bowel diseases 🏥🔬. A dedicated volunteer with MD Caravana cu Medici 🤝, she brings healthcare to underserved communities. Dr. Matran’s active membership in ESPGHAN and advisory roles showcase her impactful influence in public health policy 🌍✨.

Publication Profile

orcid

Educational Backgrounds

Assist. Prof. Dr. Roxana Matran embarked on her academic journey at the prestigious Central School in Bucharest, where she specialized in Mathematics-Informatics with bilingual French instruction (📘✏️). She continued her education at “Carol Davila” University of Medicine and Pharmacy, earning a Bachelor’s Degree in 2009 (🎓🩺). Driven by her passion for medicine, she pursued a Ph.D. at the same university, completing her thesis on factors contributing to pulmonary disease in cystic fibrosis between 2013 and 2017 (📄🫁). Her dedication and expertise in the medical field have solidified her reputation as a leading academic and researcher in Bucharest (🌟🏥).

Work Experiance

Assist. Prof. Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic based in Bucharest. She serves as a member of the Advisory Committee on Post-Vaccination Adverse Reactions, analyzing vaccine-related health concerns (💉📊). She is also a sub-investigator in pivotal clinical trials, including studies on Vedolizumab and Adalimumab for pediatric Crohn’s disease and ulcerative colitis (🔬📑). Dr. Matran volunteers with Caravana cu Medici, offering medical consultations in underserved Romanian villages (🚑🤝). As an Assistant Professor at “Carol Davila” University, she teaches fifth-year medical students and conducts extensive research (📚👩‍🔬). Her work at “Grigore Alexandrescu” Emergency Hospital focuses on consultations, rounds, and clinical studies (🏥👶).

Membership

Assist. Prof. Dr. Roxana Matran is an active member of esteemed professional organizations in her field. Since June 2019, she has been a Full Member of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN), contributing to advancements in pediatric healthcare across Europe (🌍👶🩺). Additionally, she has been a dedicated member of the Romanian Society of Pediatrics since July 2016, working to promote excellence in pediatric medicine and research in her home country (🇷🇴📚💉). Her involvement in these societies underscores her commitment to improving children’s health and staying at the forefront of medical advancements (🌟🔬).

Conference and Seminars

Assist. Prof. Dr. Roxana Matran has an extensive track record of participation in prestigious medical events and specialized training programs worldwide. In 2024, she is set to attend the 5th Liver Transplant School in Brussels (25–28 September) and the ESPGHAN Mastercourse in Parenteral Nutrition in Linz, Austria (4–6 March). Her prior engagements include the ESPGHAN IBD Masterclass in Helsinki, Finland (2022) and the International Symposium on Pediatric Inflammatory Bowel Disease in Edinburgh, Scotland (2022). Over the years, she has honed her expertise in pediatric gastroenterology, nutrition, and pulmonology, attending courses in Italy 🇮🇹, Austria 🇦🇹, France 🇫🇷, and Greece 🇬🇷, and even completing a post-graduate program online 🌐.

Community Impact

Assist. Prof. Dr. Roxana Matran is deeply committed to serving underserved communities, demonstrating her passion for equitable healthcare access. She actively volunteers with MD Caravana cu Medici, a noble initiative providing essential medical consultations in impoverished Romanian villages 🏡. Through this work, Dr. Matran brings her expertise in pediatric gastroenterology and nutrition to those who need it most, offering care, guidance, and hope 🌟. Her dedication to improving public health goes beyond the clinic, reflecting a strong sense of compassion and responsibility toward marginalized populations 🤝. Dr. Matran’s efforts exemplify the true spirit of community service and medical care ❤️.

Clinical Expertise

Assist. Prof. Dr. Roxana Matran has made significant contributions to pediatric gastroenterology through her clinical practice, research, and involvement in clinical trials. As a pediatric gastroenterologist at “Grigore Alexandrescu” Emergency Hospital for Children 🏥, she seamlessly combines patient care with groundbreaking research. Dr. Matran has actively contributed as a subinvestigator for leading pharmaceutical companies, including Takeda Pharmaceuticals (VedolizumabSC-3003) and AbbVie (Adalimumab), advancing therapies for pediatric inflammatory bowel disease 🔬. She also researches post-vaccination adverse reactions as a member of the Advisory Committee at the Ministry of Health, ensuring better health outcomes for children globally 💉.

Research Focus

Dr. Roxana Elena Smădeanu’s research focus primarily revolves around pediatric health, with a special emphasis on diagnosing and managing complex diseases such as cystic fibrosis, intestinal tuberculosis, and respiratory conditions in children. Her work includes exploring microbiota’s role in functional abdominal pain disorders, respiratory symptomatology associated with COVID-19 in pediatric patients, and rare genetic syndromes like Menke-Hennekam syndrome. Additionally, her research delves into diagnostic methods like sweat conductivity in cystic fibrosis. This body of work aligns with clinical and laboratory research aimed at improving pediatric healthcare and diagnostics. 🧑‍🔬🩺👶

Publication Top Notes

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center

Food Related Quality of Life in Children with Chronic Gastrointestinal Disorders: Comparative Study Between Inflammatory Bowel Disease and Celiac Disease—Reports from a Romanian Center

Anti TNF-a Use in Pediatric Inflammatory Bowel Disease – Reports from a Romanian Center

Quality of Life of Pediatric Patients with Chronic Intestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic

Menke–Hennekam Syndrome: A Literature Review and a New Case Report

Qingfeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Qingfeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Prof Qingfeng Chen, Guangxi University, China

Prof. Qingfeng Chen is a distinguished leader in bioinformatics, data mining, and artificial intelligence. With a Ph.D. in Computer Science from the University of Technology Sydney, he has made significant contributions to drug-target interaction prediction, RNA structure identification, and protein kinase regulation. An active academic leader, he serves as the Chairman of the Guangxi Bioinformatics Association and has held editorial roles in top journals. His extensive publication record and leadership in international conferences reflect his influence. Prof. Chen’s mentorship and dedication to advancing interdisciplinary research make him a trailblazer in his field. 📚💻🔬🌍

Publication Profile

scopus

Educational Backgrounds

Professor Qingfeng Chen holds a Doctor of Philosophy in Computer Science and Technology from the University of Technology Sydney (2004) 🎓. He earned a Master of Mathematics from Guangxi Normal University in 1998, following his Bachelor’s degree in Mathematics from the same institution in 1995 📚. His academic journey reflects a strong foundation in both mathematics and computer science, positioning him as an expert in these fields. With a distinguished academic background, Prof. Chen continues to contribute significantly to the advancement of technology and mathematical research 🔍.

Editorial Role

Prof. Qingfeng Chen is a highly regarded academic, serving as an Associated Editor for Complexity & Intelligent Systems and the Journal of Bioinformatics. He has also contributed as a Guest Editor for notable journals such as Current Protein & Peptide Science, Engineering Letters, and IAENG (International Association of Engineers). Additionally, Prof. Chen serves as a Journal Reviewer for esteemed publications, including Data Mining and Knowledge Discovery, IEEE Transactions on Knowledge and Data Engineering, IEEE Transactions on Information Technology in Biomedicine, Briefing in Bioinformatics, Information Science, Knowledge and Information Systems, and IEEE Transactions on Evolutionary Computation 📚💻🔬.

Current Position

Prof. Qingfeng Chen has held several prestigious positions throughout his career. Since July 2009, he has been a Professor of Bioinformatics, Data Mining, and Artificial Intelligence at the Department of Computer and Electronic Information, Guangxi University. He has also served as an Honorary Research Fellow at La Trobe University in Australia since May 2016. In addition, he is the Chairman of the Guangxi Bioinformatics Association (since August 2022) and the Executive Deputy Director of the Biomedical Informatics Committee of the Guangxi Artificial Intelligence Society (since August 2020). Previously, he was an Honorary Visiting Professor at the University of Technology Sydney and a Research Fellow at City University of Hong Kong 🔬🎓🌍.

Conference Leadership

Prof. Qingfeng Chen has made significant contributions to the academic community, not only through his impactful research and publications but also by showcasing his leadership in organizing key conferences. He has chaired prominent events such as the 12th International Conference on Bioinformatics and Biomedical Science (ICBBS 2023), where his expertise guided discussions on bioinformatics and biomedical advancements. Additionally, he has co-chaired several other international conferences, highlighting his dedication to advancing bioinformatics and artificial intelligence. Through these efforts, Prof. Chen continues to shape and influence the future of these rapidly evolving fields 📅💡🌍.

Extensive Research

Prof. Qingfeng Chen has published a vast array of influential papers and monographs, establishing himself as a leader in bioinformatics. His groundbreaking work in drug-target interaction prediction, RNA structure identification, and protein kinase regulation is highly respected. Notable books such as Intelligent Strategies for Pathway Mining and Secure Transaction Protocol Analysis highlight his expertise in computational biology. Prof. Chen’s journal papers, covering topics like circRNA-disease association prediction and the evolution of SARS-CoV-2, are widely cited and published in prestigious journals like IEEE Transactions on Knowledge and Data Engineering and IEEE Transactions on Computational Biology and Bioinformatics 📖🔬💡.

Research Focus

Professor Qingfeng Chen’s research primarily focuses on advanced computational biology, particularly in the integration and analysis of multi-omics data for precision medicine. His work involves developing machine learning frameworks, such as interpretable multitask learning models and graph convolutional networks, for predicting cancer outcomes, understanding immune responses, and improving drug-target interaction predictions. His research also explores the application of deep learning techniques to predict responses to therapies like immune checkpoint inhibitors. With a keen interest in cancer biology, his studies aim to enhance biomarker discovery and optimize therapeutic strategies. 🔬💡

Publication Top Notes

scMoMtF: An interpretable multitask learning framework for single-cell multi-omics data analysis

Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma

A semi-supervised approach for the integration of multi-omics data based on transformer multi-head self-attention mechanism and graph convolutional networks

Noise-Resilient Unsupervised Graph Representation Learning via Multi-Hop Feature Quality Estimation

Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma

Bi-SGTAR: A simple yet efficient model for circRNA-disease association prediction based on known association pair only

DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery

IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability

Entity Alignment Based on Dynamic Graph Attention and Label Propagation

NGCN: Drug-target interaction prediction by integrating information and feature learning from heterogeneous network

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED 🎓, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc 🏅, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). 🎓📚👨‍🎓

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. 🏥📚👨‍🏫

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. 📚🔬🧑‍🏫

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. 💼📚

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. 🏆📚🔬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. 🧑‍⚕️🍽️💊

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Published on by Top Pharmaceutical

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Assist Prof Dr Ratree Sawangjit, Mahasarakham University, Thailand

Assist. Prof. Dr. Ratree Sawangjit 🌿, a distinguished educator and researcher, has been a faculty member at Mahasarakham University’s Faculty of Pharmacy since 2006. She earned her Ph.D. in Biopharmaceutical Sciences 🧪 from Mahidol University. Her expertise spans clinical trials, herbal medicine, and evidence-based synthesis 📊. As Head of CTEBs Research Unit and IRB/EC, she leads impactful research projects. Dr. Sawangjit has held roles at Monash University 🌏 and contributed to WHO-GCTM initiatives. Recognized as an outstanding researcher 🏆, her work bridges clinical pharmacology, public health, and education, fostering innovative healthcare solutions.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Ratree Sawangjit is a distinguished academic in pharmaceutical sciences 🎓💊. She earned her Ph.D. in Biopharmaceutical Sciences (International Program) from Mahidol University, Faculty of Pharmacy, Bangkok, Thailand (2008-2012) 🧪📚. Prior to this, she completed her Master’s in Pharmacy, specializing in Pharmaceutical Sciences (International Program), at Naresuan University, Thailand (2004-2006) 🏫🔬. Her journey in pharmacy began with a Bachelor of Pharmacy degree from Chiang Mai University, Thailand (1999-2004) 🌿📖. With her extensive education and expertise, she contributes significantly to the field of biopharmaceutical sciences through teaching and research 🌟📊.

Experience

Assist. Prof. Dr. Ratree Sawangjit is a dedicated faculty member at the Department of Clinical Pharmacy, Mahasarakham University (2006–present) 📚💊. She earned her Ph.D. in Biopharmaceutical Sciences from Mahidol University 🎓 (2012) and holds advanced degrees in Pharmacy from Naresuan and Chiang Mai Universities. Dr. Sawangjit mentors students in clinical pharmacology, integrating research and practice 🧪✨. As a Clinical Research Associate (2009–2020), she contributed to impactful public health policies 🌍💡. She also led health promotion projects and served as Assistant Dean for Student Affairs (2013–2015) 🎓🤝. Currently, she heads the IRB/EC, ensuring ethical compliance in research standards ✅📋.

Research Expertise

Assist. Prof. Dr. Ratree Sawangjit is an expert in clinical trials, specializing in the design, implementation, and analysis of studies with a focus on herbal and alternative medicines 🌿🧪. She excels in evidence-based synthesis, conducting systematic reviews, meta-analyses, and network meta-analyses 📚📊. Her expertise extends to clinical pharmacology, particularly in pain and inflammation management 💊🔥. Additionally, she is proficient in health economic evaluation, including cost-effectiveness analysis and healthcare resource utilization analysis 💰🏥. Dr. Sawangjit’s work combines cutting-edge research with practical applications, advancing both patient care and healthcare efficiency. 🌟

Awards and Honors

Assist. Prof. Dr. Ratree Sawangjit is an accomplished academic and researcher. She earned a Bachelor of Pharmacy with second-class honors from Chiang Mai University in 2004 🎓💊. Supported by the Thailand Research Fund, she completed her Master’s (2004–2006) and Ph.D. (2008–2012) programs 🧠📚. As a visiting research assistance scholar, she collaborated with Monash University’s School of Pharmacy in Malaysia (2015–2016) 🌏🔬. She was named Outstanding Researcher of the Faculty of Pharmacy at Mahasarakham University in 2019 and Outstanding Researcher of Mahasarakham University in 2021 🏆✨. Her journey reflects dedication to advancing pharmaceutical education and research. 🌟

Research Focus

Assist. Prof. Dr. Ratree Sawangjit’s research focuses on evidence-based healthcare, particularly through systematic reviews and meta-analyses. Her studies span diverse areas, including burn wound healing 🌱🔥, pharmacological treatments for dementia-related agitation 🧠💊, peripheral neuropathy 🌐🦶, and nonalcoholic fatty liver disease 🩺🫀. She has also investigated the cost-effectiveness of genetic testing in preventing drug-induced reactions 🧬💉 and assessed cannabis and cannabinoids for pain management 🌿🤕. Other key areas include treatments for eczema 🧴🛁 and musculoskeletal pain 🦴🩹. Dr. Sawangjit’s work significantly contributes to optimizing therapeutic interventions and advancing global health outcomes. 🌍📚

Publication Top Notes

The efficacy of aloe vera used for burn wound healing: a systematic review

Cost-effectiveness analysis of HLA-B* 5801 testing in preventing allopurinol-induced SJS/TEN in Thai population

Effectiveness of pharmacy‐based needle/syringe exchange programme for people who inject drugs: a systematic review and meta‐analysis

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis

Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis

 

 

 

Dvora Joseph Davey | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Dvora Joseph Davey | Clinical Trials | Best Researcher Award 

Dr Dvora Joseph Davey, University of California, Los Angeles, UCLA, South Africa

Dr. Dvora Joseph Davey is a distinguished epidemiologist with a focus on infectious diseases, particularly HIV and STIs. Holding a Ph.D. in Epidemiology from UCLA, her research, mainly in sub-Saharan Africa, aims to reduce the burden of HIV through innovative interventions. As a Principal Investigator in clinical trials, Dr. Davey has contributed significantly to global HIV prevention efforts, especially for pregnant women. She is actively involved in policy-making with groups like the WHO and NIH, shaping global health initiatives. Her leadership, extensive research, and mentorship in global health make her an exemplary figure in public health. 🌍🔬💉

Publication Profile

google scholar

scopus

orcid

Education

Dr. Dvora Joseph Davey has an impressive academic background, beginning with a B.A. in International Affairs and French from the University of Colorado, Boulder, in 1998. She went on to earn a Master of Public Health (M.P.H.) in Population and Reproductive Health Sciences from Columbia University in 2003. Dr. Davey completed her Ph.D. in Epidemiology at the University of California, Los Angeles, in 2016, followed by a fellowship in Epidemiology of HIV at the University of North Carolina in 2017. She furthered her expertise with a postdoctoral fellowship in Global HIV Prevention at UCLA in 2018. 🌍📚

Scientific Appointments

Dr. Dvora Joseph Davey has held several prestigious positions throughout her career. Currently, she serves as an Associate Professor in Infectious Diseases and Epidemiology at UCLA’s School of Medicine and School of Public Health, respectively. She also holds honorary roles at the University of Cape Town and Desmond Tutu Health Foundation. Dr. Davey’s research includes being the Principal Investigator on a study about sexual behavior and PrEP acceptability. Her past positions include HIV Director at Population Services International in Mozambique and Director at the Rwanda-Emory HIV Research Group. With her diverse roles, Dr. Davey has had a significant global impact. 🌍🩺📊

Professional Memberships

Dr. Dvora Joseph Davey has made significant contributions to the field of HIV and reproductive health, serving as an Assistant Editor for renowned journals such as AIDS, JIAS, and PloS Global Health. She is also an active member of the South African Clinical Research Association and the American Public Health Association. Her honors include invitations to present at major conferences like HIVR4P 2024 in Peru and WHO Working Group meetings. Dr. Davey has co-chaired several influential research working groups, including on PrEP in pregnancy, and received multiple awards, including UCLA’s Epidemiology Department Summer Fellowship. 🌍📚🎤

Awards

Dr. Dvora Joseph Davey is a renowned researcher whose work focuses on HIV prevention and treatment, particularly in pregnant and breastfeeding women. Her studies address key challenges in high HIV incidence communities, especially in Sub-Saharan Africa. Dr. Davey investigates Pre-exposure Prophylaxis (PrEP) access, adherence, and effectiveness among pregnant women, emphasizing the need for female-controlled HIV prevention methods during vulnerable periods. Additionally, she explores the integration of STI testing, alcohol use, and the impact of intimate partner violence on HIV risk. Her contributions significantly influence HIV-related healthcare policies, aiming to reduce transmission and improve outcomes in these populations. 👩‍🔬🌍💉

Policy Involvement

Dr. Dvora Joseph Davey has made significant contributions to national and international HIV and STI policy-making. Her leadership in key working groups, including the National PrEP and Prevention of Vertical Transmission of HIV Working Groups, as well as the World Health Organization’s Working Group on Long-Acting PrEP in pregnancy, highlights her expertise and influence. These positions enable Dr. Davey to play a pivotal role in translating scientific research into actionable policies, ensuring her work impacts not only the scientific community but also global health policies. Her efforts amplify the reach of her research, making a lasting impact on public health worldwide. 🌍🩺💉

Leadership

Dr. Dvora Joseph Davey’s leadership in managing large-scale clinical trials and mentoring emerging public health and epidemiology professionals showcases her dedication to education and capacity-building in global public health. As a recipient of the prestigious NIH/Fogarty International Research Scientist Development Award (IRSDA) and the follow-on R01 award, Dr. Davey has solidified her position as a thought leader in the field. Her commitment to fostering continuous learning and improvement within the global health community reflects her deep influence and dedication to advancing public health practices worldwide. 🎓🌍💉👩‍🔬

Ongoing Projects

Dr. Dvora Joseph Davey’s ongoing research, supported by NIH and Gilead Corporation, plays a crucial role in addressing HIV within vulnerable populations. Her work on projects like PrEP-PP and SCOPE-PP, alongside innovative initiatives such as a community-based peer-led intervention to tackle alcohol use and HIV risk in pregnant women, highlights her proactive approach to solving complex public health challenges. Dr. Davey’s research aims to create effective, targeted solutions that address the unique needs of at-risk communities, contributing significantly to advancing HIV prevention and care efforts. 💡🧑‍🔬🩺🌍

Research Focus

Dr. Dvora Joseph Davey is a prominent researcher specializing in HIV prevention, sexually transmitted infections (STIs), and maternal health. Her work focuses on pre-exposure prophylaxis (PrEP) for HIV, examining its safety and efficacy among pregnant and postpartum women. She also explores STI diagnostics, point-of-care testing, and the prevalence of curable STIs in low- and middle-income countries. Her research seeks to improve access to health interventions, particularly for vulnerable populations like men who have sex with men and transgender women. Dr. Davey’s contributions help shape public health strategies for HIV prevention and sexual health. 🦠💉

Publication Top Notes